Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jespersen

Showing results (111-120 of 204) with videos related to

Pageof 21
Sort By:
Thrombosis and Haemostasis|February 1, 1995
Dietary changes in fasting levels of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteinsE M Bladbjerg, T Tholstrup, P Marckmann, et al.
Human Reproduction (Oxford, England)|November 29, 2002
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitorE M Bladbjerg, S O Skouby, L F Andersen, et al.
Thrombosis and Haemostasis|November 15, 1993
Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1)P J Declerck, H Moreau, J Jespersen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 19, 2005
Lack of hepatic metabolism of C-telopeptides of type I collagenP Qvist, K R Petersen, J Jespersen, et al.
Clinical and Vaccine Immunology : CVI|April 30, 2010
Evaluation of the Bio-Rad BioPlex 2200 syphilis multiplex flow immunoassay for the detection of IgM- and IgG-class antitreponemal antibodiesE Gomez, D J Jespersen, J A Harring, et al.
Coronary Artery Disease|May 1, 1997
Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarctionO D Pedersen, J Gram, X Jeunemaitre, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1985
Subcutaneous heparin in the treatment of interstitial cystitisG Lose, J Jespersen, B Frandsen, et al.
Thrombosis Research|August 15, 1985
Plasma histidine-rich glycoprotein and plasminogen in patients with liver diseaseJ Gram, J Jespersen, S Ingeberg, et al.
Coronary Artery Disease|July 1, 1994
Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diureticsO D Pedersen, J Gram, H Bagger, et al.
European Heart Journal|June 1, 1993
Depression of factor XII-dependent fibrinolytic activity in survivors of acute myocardial infarction at risk of reinfarctionO D Pedersen, S Munkvad, J Gram, et al.
Pageof 21

Showing results (111-120 of 204) with videos related to

Sort By:
Pageof 21
Thrombosis and Haemostasis|February 1, 1995
Dietary changes in fasting levels of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteinsE M Bladbjerg, T Tholstrup, P Marckmann, et al.
Human Reproduction (Oxford, England)|November 29, 2002
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitorE M Bladbjerg, S O Skouby, L F Andersen, et al.
Thrombosis and Haemostasis|November 15, 1993
Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1)P J Declerck, H Moreau, J Jespersen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 19, 2005
Lack of hepatic metabolism of C-telopeptides of type I collagenP Qvist, K R Petersen, J Jespersen, et al.
Clinical and Vaccine Immunology : CVI|April 30, 2010
Evaluation of the Bio-Rad BioPlex 2200 syphilis multiplex flow immunoassay for the detection of IgM- and IgG-class antitreponemal antibodiesE Gomez, D J Jespersen, J A Harring, et al.
Coronary Artery Disease|May 1, 1997
Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarctionO D Pedersen, J Gram, X Jeunemaitre, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1985
Subcutaneous heparin in the treatment of interstitial cystitisG Lose, J Jespersen, B Frandsen, et al.
Thrombosis Research|August 15, 1985
Plasma histidine-rich glycoprotein and plasminogen in patients with liver diseaseJ Gram, J Jespersen, S Ingeberg, et al.
Coronary Artery Disease|July 1, 1994
Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diureticsO D Pedersen, J Gram, H Bagger, et al.
European Heart Journal|June 1, 1993
Depression of factor XII-dependent fibrinolytic activity in survivors of acute myocardial infarction at risk of reinfarctionO D Pedersen, S Munkvad, J Gram, et al.
Pageof 21